| 常用名 | 1-(4-氰基苄基)-1H-5-羟基甲基咪唑 | CAS号 | 183500-36-9 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: CYP19A1/CYP11B2-IN-1 (Compound X21) is a potent and selective aromatase and aldosterone synthase dual inhibitor with IC50s of 2.3 nM and 29 nM for aromatase (CYP19A1) and aldosterone synthase (CYP11B2), respectively. CYP19A1/CYP11B2-IN-1 has excellent antiproliferative and pro-apoptotic activity against the cancer cell. CYP19A1/CYP11B2-IN-1 can be used for research of breast cancer[1]. 物理化学性质: CAS号:183500-36-9 常用中文名:1-(4-氰基苄基)-1H-5-羟基甲基咪唑 常用英文名:4-(5-HYDROXYMETHYLIMIDAZOL-1-YLMETHYL)BENZONITRILE 分子式:C12H11N3O 分子量:213.23500 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |